DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern

Journal Article · · Scientific Reports

Abstract The glycosylation on the spike (S) protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, modulates the viral infection by altering conformational dynamics, receptor interaction and host immune responses. Several variants of concern (VOCs) of SARS-CoV-2 have evolved during the pandemic, and crucial mutations on the S protein of the virus have led to increased transmissibility and immune escape. In this study, we compare the site-specific glycosylation and overall glycomic profiles of the wild type Wuhan-Hu-1 strain (WT) S protein and five VOCs of SARS-CoV-2: Alpha, Beta, Gamma, Delta and Omicron. Interestingly, both N- and O-glycosylation sites on the S protein are highly conserved among the spike mutant variants, particularly at the sites on the receptor-binding domain (RBD). The conservation of glycosylation sites is noteworthy, as over 2 million SARS-CoV-2 S protein sequences have been reported with various amino acid mutations. Our detailed profiling of the glycosylation at each of the individual sites of the S protein across the variants revealed intriguing possible association of glycosylation pattern on the variants and their previously reported infectivity. While the sites are conserved, we observed changes in the N- and O-glycosylation profile across the variants. The newly emerged variants, which showed higher resistance to neutralizing antibodies and vaccines, displayed a decrease in the overall abundance of complex-type glycans with both fucosylation and sialylation and an increase in the oligomannose-type glycans across the sites. Among the variants, the glycosylation sites with significant changes in glycan profile were observed at both the N -terminal domain and RBD of S protein, with Omicron showing the highest deviation. The increase in oligomannose-type happens sequentially from Alpha through Delta. Interestingly, Omicron does not contain more oligomannose-type glycans compared to Delta but does contain more compared to the WT and other VOCs. O-glycosylation at the RBD showed lower occupancy in the VOCs in comparison to the WT. Our study on the sites and pattern of glycosylation on the SARS-CoV-2 S proteins across the VOCs may help to understand how the virus evolved to trick the host immune system. Our study also highlights how the SARS-CoV-2 virus has conserved both N - and O - glycosylation sites on the S protein of the most successful variants even after undergoing extensive mutations, suggesting a correlation between infectivity/ transmissibility and glycosylation.

Sponsoring Organization:
USDOE
Grant/Contract Number:
SC0015662
OSTI ID:
1986101
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 13; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (51)

Byonic: Advanced Peptide and Protein Identification Software journal December 2012
Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination journal December 2021
Glycomic and glycoproteomic analysis of glycoproteins—a tutorial journal June 2017
Glycosylation of SARS-CoV-2: structural and functional insights journal July 2021
A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates journal May 1992
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines journal July 2021
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 journal November 2020
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States journal May 2021
Antibody evasion by the P.1 strain of SARS-CoV-2 journal March 2021
Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development journal January 2022
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro journal December 2021
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape journal May 2022
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies journal January 2022
Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition journal February 2021
Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic journal January 2022
Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics journal February 2023
The Delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2 journal March 2022
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein journal January 2021
Tool for Rapid Analysis of Glycopeptide by Permethylation via One-Pot Site Mapping and Glycan Analysis journal October 2017
High-Throughput Automated Micro-permethylation for Glycan Structure Analysis journal December 2018
Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike journal March 2021
GlycoWorkbench: A Tool for the Computer-Assisted Annotation of Mass Spectra of Glycans journal April 2008
Heavily mutated Omicron variant puts scientists on alert journal November 2021
O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule journal August 2021
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron journal January 2022
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants journal February 2022
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants journal February 2021
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 journal April 2021
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications journal May 2021
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant journal August 2021
Waning Immunity after the BNT162b2 Vaccine in Israel journal December 2021
Furin cleavage of the SARS-CoV-2 spike is modulated by O -glycosylation journal November 2021
The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses journal April 2021
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 journal October 2020
Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein journal May 2021
Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants journal September 2021
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants journal February 2023
The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis journal April 2003
Global aspects of viral glycosylation journal March 2018
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc journal April 2008
Site-specific glycan analysis of the SARS-CoV-2 spike journal May 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 journal August 2020
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants journal August 2021
Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization journal August 2007
A Single-Amino-Acid Substitution in Herpes Simplex Virus 1 Envelope Glycoprotein B at a Site Required for Binding to the Paired Immunoglobulin-Like Type 2 Receptor α (PILRα) Abrogates PILRα-Dependent Viral Entry and Reduces Pathogenesis journal October 2010
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? journal March 2022
A Strategy for O-Glycoproteomics of Enveloped Viruses—the O-Glycoproteome of Herpes Simplex Virus Type 1 journal April 2015
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants journal February 2022
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel journal July 2021
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2? journal February 2021
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells journal March 2021

Similar Records

Related Subjects